Search Results - Moradi, Monireh Haji

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Phase II, Safety and Immunogenicity of RAZI Cov Pars (RCP) SARS Cov-2 Vaccine in Adults Aged 18–70 Years; A Randomized, Double-Blind Clinical Trial

    Phase II, Safety and Immunogenicity of RAZI Cov Pars (RCP) SARS Cov-2 Vaccine in Adults Aged 18–70 Years; A Randomized, Double-Blind Clinical Trial by Mohazzab, Arash, Fallah Mehrabadi, Mohammad Hossein, Es-haghi, Ali, Kalantari, Saeed, Mokhberalsafa, Ladan, Setarehdan, Seyed Amin, Sadeghi, Fariba, Rezaei Mokarram, Ali, Haji Moradi, Monireh, Razaz, Seyad Hossein, Taghdiri, Maryam, Ansarifar, Akram, Lotfi, Mohsen, Khorasani, Akbar, nofeli, Mojtaba, Masoumi, Safdar, Boluki, Zahra, Erfanpoor, Saeed, Bagheri Amiri, Fahimeh, Esmailzadehha, Neda, Filsoof, Sara, Mohseni, Vahideh, Ghahremanzadeh, Neda, Safari, Shiva, Shahsavan, Masoumeh, Bayazidi, Shnoo, Raghami Derakhshani, Maryam, Rabiee, Mohammad Hasan, Golmoradi-Zadeh, Rezvan, Khodadoost, Behnam, Solaymani-Dodaran, Masoud, Banihashemi, Seyed Reza

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Analysis of immunological and biochemical parameters after booster dose vaccination using protein-based and inactivated virus vaccine for safety

    Analysis of immunological and biochemical parameters after booster dose vaccination using protein-based and inactivated virus vaccine for safety by Malek, Esmat, Fallah Mehrabadi, Mohammad Hossein, Es-haghi, Ali, Nofeli, Mojtaba, Mokaram, Ali Rezae, Moradi, Monireh Haji, Razaz, Seyad Hossein, Solaymani-Dodaran, Masoud, Kalantari, Saeed, Sadeghi, Fariba, Mokhberalsafa, Ladan, Banihashemi, Seyed Reza

    Published in Heliyon
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial

    Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial by Solaymani-Dodaran, Masoud, Kalantari, Saeed, Banihashemi, Seyed Reza, Es-haghi, Ali, Nofeli, Mojtaba, Mohazzab, Arash, Mokhberalsafa, Ladan, Sadeghi, Fariba, Mokaram, Ali Rezae, Moradi, Monireh Haji, Razaz, Seyad Hossein, Taghdiri, Maryam, Lotfi, Mohsen, Setarehdan, Seyed Amin, Masoumi, Safdar, Ansarifar, Akram, Ebrahimi, Saeedeh, Esmailzadehha, Neda, Boluki, Zahra, Khoramdad, Malihe, Molaipour, Leila, Rabiei, Mohamad Hassan, Amiri, Fahimeh Bagheri, Filsoof, Sara, Bani-vaheb, Behrooz, Derakhshani, Maryam Raghami, Bayazidi, Sheno, Golmoradizadeh, Rezvan, Shahsavan, Masoumeh, Safari, Shiva, Ghahremanzadeh, Neda, Mohseni, Vahideh, Erfanpoor, Saeed, Fallah Mehrabadi, Mohammad Hossein

    Published in Heliyon
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: